18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions

Prostatic Neoplasms

Interventions

DRUG

18F- DCFPyL PET/CT

A CT scan using a radioactive marker to better image tumors

Trial Locations (1)

Columbia University Irving Medical Center, New York

All Listed Sponsors

lead

Columbia University

OTHER

NCT03824275 - 18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer | Biotech Hunter | Biotech Hunter